SUPRIYA LIFESCIENCE
|
The Current P/E Ratio of SUPRIYA LIFESCIENCE is 36.96.
Share Price | ₹723.2 | Jan 06,2025 |
Market Cap | ₹5,821.4 Cr | |
Earnings-TTM | ₹157.5 Cr | TTM-Standalone Results |
Price/Earnings | 36.96x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SUPRIYA LIFESCIENCE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹5,821.4 Cr] as on Jan 06,2025
(/) Earnings [ ₹157.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 36.96x ]
Thus, for SUPRIYA LIFESCIENCE , the investors are currently willing to pay 36.96 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUPRIYA LIFESCIENCE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SUPRIYA LIFESCIENCE over the last five years.
Historical PE (Price/Earnings) ratio chart of SUPRIYA LIFESCIENCE
PE Ratio Performance Analysis for SUPRIYA LIFESCIENCE
- SUPRIYA LIFESCIENCE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 13.13x.
- SUPRIYA LIFESCIENCE 's operated at median p/e ratio of 17.08x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUPRIYA LIFESCIENCE 's p/e ratio peaked in Mar2022 at 26.13x.
- SUPRIYA LIFESCIENCE 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does SUPRIYA LIFESCIENCE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SUPRIYA LIFESCIENCE | 157.51 | 36.96 | 5,821.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 39.79 | 443,145.0 |
CIPLA LTD | 4,485.22 | 26.84 | 120,379.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.84 | 112,701.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.51 | 96,774.5 |
DIVIS LABORATORIES LTD | 1,836.00 | 85.12 | 156,280.0 |
MANKIND PHARMA LTD | 2,124.86 | 56.02 | 119,028.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 63.00 | 113,526.0 |
LUPIN LTD | 2,651.94 | 40.56 | 107,569.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 21.20 | 76,299.9 |
ABBOTT INDIA LTD | 1,284.66 | 49.52 | 63,619.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUPRIYA LIFESCIENCE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.84x |
Max industry PE | 85.12x |
Median industry PE | 39.79x |
Average industry PE | 42.03x |
You may also like the below Video Courses